Xintela Ab Stock Net Income
| XINT Stock | SEK 0.27 0.01 3.85% |
As of the 19th of February, Xintela AB maintains the Downside Deviation of 4.97, market risk adjusted performance of (3.35), and Mean Deviation of 2.69. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xintela AB, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from Xintela AB's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Xintela AB's valuation are summarized below:Xintela AB does not presently have any fundamental gauges for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Xintela |
Xintela AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Xintela AB's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Xintela AB.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Xintela AB on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Xintela AB or generate 0.0% return on investment in Xintela AB over 90 days. Xintela AB is related to or competes with Elicera Therapeutics, Intervacc, Acarix AS, Ascelia Pharma, Mendus AB, Karolinska Development, and Nanexa AB. Xintela AB , a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage dam... More
Xintela AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Xintela AB's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Xintela AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.97 | |||
| Information Ratio | 0.0056 | |||
| Maximum Drawdown | 15.72 | |||
| Value At Risk | (6.90) | |||
| Potential Upside | 6.67 |
Xintela AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xintela AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Xintela AB's standard deviation. In reality, there are many statistical measures that can use Xintela AB historical prices to predict the future Xintela AB's volatility.| Risk Adjusted Performance | 0.0223 | |||
| Jensen Alpha | 0.0581 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.0042 | |||
| Treynor Ratio | (3.36) |
Xintela AB February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0223 | |||
| Market Risk Adjusted Performance | (3.35) | |||
| Mean Deviation | 2.69 | |||
| Semi Deviation | 3.13 | |||
| Downside Deviation | 4.97 | |||
| Coefficient Of Variation | 5475.32 | |||
| Standard Deviation | 3.69 | |||
| Variance | 13.64 | |||
| Information Ratio | 0.0056 | |||
| Jensen Alpha | 0.0581 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.0042 | |||
| Treynor Ratio | (3.36) | |||
| Maximum Drawdown | 15.72 | |||
| Value At Risk | (6.90) | |||
| Potential Upside | 6.67 | |||
| Downside Variance | 24.69 | |||
| Semi Variance | 9.81 | |||
| Expected Short fall | (4.51) | |||
| Skewness | (0.14) | |||
| Kurtosis | (0.28) |
Xintela AB Backtested Returns
Currently, Xintela AB is out of control. Xintela AB shows Sharpe Ratio of close to zero, which attests that the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Xintela AB, which you can use to evaluate the volatility of the company. Please check out Xintela AB's Market Risk Adjusted Performance of (3.35), mean deviation of 2.69, and Downside Deviation of 4.97 to validate if the risk estimate we provide is consistent with the expected return of 4.0E-4%. The firm maintains a market beta of -0.0171, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Xintela AB are expected to decrease at a much lower rate. During the bear market, Xintela AB is likely to outperform the market. Xintela AB right now maintains a risk of 3.62%. Please check out Xintela AB total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to decide if Xintela AB will be following its historical returns.
Auto-correlation | -0.44 |
Modest reverse predictability
Xintela AB has modest reverse predictability. Overlapping area represents the amount of predictability between Xintela AB time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Xintela AB price movement. The serial correlation of -0.44 indicates that just about 44.0% of current Xintela AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.44 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Xintela AB reported net income of (58.39 Million). This is 117.11% lower than that of the Healthcare sector and 183.37% lower than that of the Biotechnology industry. The net income for all Sweden stocks is 110.23% higher than that of the company.
Xintela Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xintela AB's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xintela AB could also be used in its relative valuation, which is a method of valuing Xintela AB by comparing valuation metrics of similar companies.Xintela AB is currently under evaluation in net income category among its peers.
Xintela Fundamentals
| Return On Equity | -4.69 | |||
| Return On Asset | -1.14 | |||
| Current Valuation | 122.93 M | |||
| Shares Outstanding | 307.57 M | |||
| Shares Owned By Insiders | 58.76 % | |||
| Price To Earning | (4.40) X | |||
| Price To Book | 11.52 X | |||
| Price To Sales | 5,115 X | |||
| Gross Profit | 2.08 M | |||
| EBITDA | (54.43 M) | |||
| Net Income | (58.39 M) | |||
| Cash And Equivalents | 11.14 M | |||
| Cash Per Share | 0.53 X | |||
| Current Ratio | 6.13 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (42.89 M) | |||
| Earnings Per Share | (0.73) X | |||
| Number Of Employees | 16 | |||
| Beta | 1.45 | |||
| Market Capitalization | 143.79 M | |||
| Total Asset | 24.74 M | |||
| Z Score | -6.6 | |||
| Net Asset | 24.74 M |
About Xintela AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xintela AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xintela AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xintela AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xintela Stock Analysis
When running Xintela AB's price analysis, check to measure Xintela AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xintela AB is operating at the current time. Most of Xintela AB's value examination focuses on studying past and present price action to predict the probability of Xintela AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xintela AB's price. Additionally, you may evaluate how the addition of Xintela AB to your portfolios can decrease your overall portfolio volatility.